PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+35.59%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$9.28B
AUM Growth
+$9.28B
(+37%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
12.62%
Top 10 Holdings %
Top 10 Hldgs %
43.31%
Holding
162
New
36
Increased
23
Reduced
15
Closed
21
Top Buys
| 1 |
NVTA
Invitae Corporation
NVTA
|
$305M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$226M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$130M |
| 4 |
C4 Therapeutics
CCCC
|
$105M |
| 5 |
KRON
Kronos Bio
KRON
|
$83M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$190M |
| 2 |
CRISPR Therapeutics
CRSP
|
$112M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$77.6M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$61.6M |
| 5 |
Kodiak Sciences
KOD
|
$42.8M |
Sector Composition
| 1 | Healthcare | 85.79% |
| 2 | Industrials | 0.29% |
| 3 | Materials | 0.22% |
| 4 | Financials | 0.13% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Verrica Pharmaceuticals
VRCA
$49.4M
| $39.3M | 0.42% |
3,410,412
| – | – |
|
|
SAGE
52
DELISTED
Sage Therapeutics
SAGE
| $38.1M | 0.41% |
+440,000
| New | +$38.1M |
|
53
Lyra Therapeutics
LYRA
$11.8M
| $36.7M | 0.39% |
3,222,561
| – | – |
|
54
VYNE Therapeutics
VYNE
$8.09M
| $36.1M | 0.39% |
22,876,410
| – | – |
|
55
Cogent Biosciences
COGT
$1.83B
| $35.8M | 0.38% |
3,188,750
-4,766,250
| -60% | +$13.5M |
|
|
NEPT
56
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $34.7M | 0.37% |
22,214,683
+2,777,777
| +14% | +$4.33M |
|
57
ADMA Biologics
ADMA
$4.03B
| $32.3M | 0.35% |
16,584,802
| – | – |
|
58
Avidity Biosciences
RNA
$6.12B
| $31.5M | 0.34% |
1,235,818
| – | – |
|
59
RAPT Therapeutics
RAPT
$187M
| $31.2M | 0.33% |
+1,577,481
| New | +$31.2M |
|
|
ISEE
60
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $31M | 0.33% |
4,482,713
+1,001,282
| +29% | +$6.92M |
|
|
SILK
61
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $29.3M | 0.31% |
465,100
-55,000
| -11% | -$3.46M |
|
62
Allogene Therapeutics
ALLO
$249M
| $28.9M | 0.31% |
1,143,790
| – | – |
|
63
MacroGenics
MGNX
$121M
| $28.8M | 0.31% |
1,261,060
-30,121
| -2% | -$689K |
|
64
Veru
VERU
$48.5M
| $28.1M | 0.3% |
3,250,000
+1,600,000
| +97% | +$13.8M |
|
|
ACCD
65
DELISTED
Accolade, Inc. Common Stock
ACCD
| $27.3M | 0.29% |
626,591
+333,453
| +114% | +$14.5M |
|
|
CNCE
66
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $27.2M | 0.29% |
2,150,641
| – | – |
|
67
Immatics
IMTX
$662M
| $27M | 0.29% |
2,500,000
| – | – |
|
68
Regeneron Pharmaceuticals
REGN
$59.8B
| $26.7M | 0.29% |
55,175
+50,175
| +1,004% | +$24.2M |
|
69
Pulmonx
LUNG
$67.6M
| $26.6M | 0.29% |
+385,000
| New | +$26.6M |
|
|
FUSN
70
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $26.3M | 0.28% |
2,235,983
| – | – |
|
71
Establishment Labs
ESTA
$1.11B
| $26.2M | 0.28% |
696,633
+18,000
| +3% | +$678K |
|
72
AnaptysBio
ANAB
$630M
| $25.7M | 0.28% |
+1,195,336
| New | +$25.7M |
|
73
4D Molecular Therapeutics
FDMT
$302M
| $24.9M | 0.27% |
+600,256
| New | +$24.9M |
|
|
ONEM
74
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $22.7M | 0.24% |
519,844
+240,000
| +86% | +$10.5M |
|
|
NSTG
75
DELISTED
NanoString Technologies, Inc.
NSTG
| $22.6M | 0.24% |
+337,800
| New | +$22.6M |
|